Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Tonix Pharmaceuticals Holding Corp.: Increased authorized common stock from 150,000,000 to 1,000,000,000 shares (effective 2022-12-13).
- Change
- charter amendment
- Effective
- 2022-12-13
Exact text from the filing
Tonix Pharmaceuticals Holding Corp. (the “Company”) filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada to increase the number of authorized shares of the Company’s common stock from 150,000,000 to 1,000,000,000 shares (the “Charter Amendment”).
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Tonix Pharmaceuticals Holding Corp. shareholders approved Adjournment of the Special Meeting to solicit additional proxies if necessary.
- Outcome
- passed
Exact text from the filing
Proposal 2 The Company’s shareholders approved a proposal for the adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes to approve Proposal 1, as set forth below: Votes For Votes Against Abstentions Broker Non-Votes 20,060,382 5,967,057 316,516 N/A
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Tonix Pharmaceuticals Holding Corp. shareholders approved Amendment to Articles of Incorporation to increase authorized shares of common stock from 150,000,000 to 1,000,000,000.
- Proposal
- charter amendment
- Outcome
- passed
Exact text from the filing
Proposal 1 The Company’s shareholders approved an amendment to the Company’s Articles of Incorporation, as amended, to increase the Company’s authorized shares of common stock from 150,000,000 to 1,000,000,000, as set forth below: Votes For Votes Against Abstentions Broker Non-Votes 242,748,061 46,849,004 746,889 N/A
View on SEC.gov